Our novel therapies for retinal disease are designed to restore vision, stop progression of underlying disease, and require fewer treatments.

ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, lif...